Allurion Technologies Inc. (ALUR) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Natick, MA, 미국. 현재 CEO는 Samuel G. Levy.
ALUR 을(를) 보유 IPO 날짜 2021-03-29, 134 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $6.79M.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.